Anti-Cytochrome P450 26C1 [T6P1C7*E7]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 152157 |
Applications | IHC WB |
Antigen/Gene or Protein Targets | Cytochrome P450, family 26, subfamily C, polypeptide 1 (CYP26C1) |
Reactivity | Human, Mouse and Rat |
Relevance | CYP26C1 is not expressed in in colorectal cancer but detected in the liver. |
Host | Mouse |
Immunogen | Ovalbumin-conjugated synthetic peptide RWELATPAFP (C-terminal sequence) |
Positive Control | IHC: formalin-fixed, paraffin-embedded human liver sections. western blot: overexpression lysates. |
Subclass | IgG1 kappa |
Myeloma Used | P3X63Ag8.653 |
Recommended Growing Conditions | Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine). |
Strain | Balb/c |
Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References: 2 entries
Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339.
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.
Europe PMC ID: 24608339
Add a reference
References: 2 entries
Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339.
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.
Add a reference